TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/22/2026
Back to search
Official data from USPTO
MYR PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
07/23/2026
Trademark type
Combined
Nice classes
5, 44
Filing date
10/26/2020
Registration date
04/05/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/05/2022
Last transaction
07/23/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
16
Owner location
DE
Examiner
NEVILLE, BRIAN
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "MYR PHARMACEUTICALS" in gray next to two quadrilaterals in gray and a triangle in red, with the letters "MYR" in white in the triangle.
Holders and representatives
Holders
MYR GmbH
Representatives
Shelley Lai Gilead Sciences, Inc.
Technical classification
Nice Classes
Class 5Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of liverviralinfectious diseases; pharmaceutical preparations for hepatic diseases or disorders; pharmaceutical preparations for hepatitis D
Class 44
Providing information in the medical field
Publications
History of USPTO decisions and trademark events.
37 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/22/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/22/2026
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
02/24/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
10/08/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/26/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/25/2022
FIMP
FINAL DISPOSITION PROCESSED
08/25/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/05/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
04/05/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/18/2022
PUBO
PUBLISHED FOR OPPOSITION
01/18/2022
GPNX
NOTIFICATION PROCESSED BY IB
01/15/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/29/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/29/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/29/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/15/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/24/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/24/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/24/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/22/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/22/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/22/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/22/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/22/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/06/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/02/2021
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
07/30/2021
RFNT
REFUSAL PROCESSED BY IB
06/21/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/24/2021
RFRR
REFUSAL PROCESSED BY MPU
05/24/2021
MAFR
APPLICATION FILING RECEIPT MAILED
05/22/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/21/2021
CNRT
NON-FINAL ACTION WRITTEN
05/20/2021
DOCK
ASSIGNED TO EXAMINER
05/18/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/18/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/13/2021
Continuous trademark protection
Get notified about every new filing that threatens MYR PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.